CIK: 0001388551
Total reported value
$4.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Synta Pharmaceuticals CORP | Stock-Other | 92.06% | — | +0.01% | |
| 2 | ✓ | Celator Pharmaceuticals INC | Stock-Other | 5.07% | — | — | |
| 3 | ALKS | Alkermes plc | Stock-Healthcare | 1.40% | — | — | |
| 4 | PSEC | Prospect Capital CORP | Stock-Other | 0.52% | — | — | |
| 5 | SLRC | Slr Investment CORP | Stock-Other | 0.23% | — | — | |
| 6 | AGRXUSD | Agile Therapeutics INC | Stock-Other | 0.21% | — | +8.13% | |
| 7 | MCCUSD | Medley Capital CORP | Stock-Other | 0.17% | — | — | |
| 8 | ✓ | Cm Fin INC | Stock-Other | 0.14% | — | — | |
| 9 | EVF | Eaton Vance Senior Income Tr | Stock-Other | 0.11% | — | — | |
| 10 | ✓ | Nuveen | Stock-Other | 0.08% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AGRXUSD | Agile Therapeutics INC | — | +8.13% | Add |
| 2 | ✓ | Celator Pharmaceuticals INC | -0.8% | — | Unchanged |
| 3 | ✓ | Synta Pharmaceuticals CORP | -1.5% | +0.01% | Add |
| 4 | ALKS | Alkermes plc | — | NEW | New buy |
| 5 | PSEC | Prospect Capital CORP | — | NEW | New buy |
| 6 | ✓ | — | EXIT | Sold out | |
| 7 | SLRC | Slr Investment CORP | — | NEW | New buy |
| 8 | MCCUSD | Medley Capital CORP | — | NEW | New buy |
| 9 | ✓ | Cm Fin INC | — | NEW | New buy |
| 10 | EVF | Eaton Vance Senior Income Tr | — | NEW | New buy |
| 11 | ✓ | Nuveen | — | NEW | New buy |